Meta-analysis of Associations of the Ezrin Gene with Human Osteosarcoma Response to Chemotherapy and Prognosis |
Wang, Zhe
(Graduate School of Guangxi Medical University)
He, Mao-Lin (Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University) Zhao, Jin-Min (Department of Orthopedic Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University) Qing, Hai-Hui (Graduate School of Guangxi Medical University) Wu, Yang (Graduate School of Guangxi Medical University) |
1 | Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselcuk F (2007). Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol, 13, 3726-9. |
2 | Boldrini E, Peres SV, Morini S, de Camargo B (2010). Immunoexpression of Ezrin and CD44 in patients with osteosarcoma. J Pediatr Hematol Oncol, 32, e213-7. DOI ScienceOn |
3 | Brambilla D, Fais S (2009). The Janus-faced role of ezrin in “linking” cells to either normal or metastatic phenotype. Int J Cancer, 125, 2239-45. DOI ScienceOn |
4 | Bretscher A, Edwards K, Fehon RG (2002). ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol, 3, 586-99. DOI ScienceOn |
5 | Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M (2005). The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res, 7, R365-73. DOI ScienceOn |
6 | Federici C, Brambilla D, Lozupone F, et al (2009). Pleiotropic function of ezrin in human metastatic melanomas. Int J Cancer, 124, 2804-12. DOI ScienceOn |
7 | Foster L, Dall GF, Reid R, Wallace WH, Porter DE (2007). Twentieth-century survival from osteosarcoma in childhood. Trends from 1933 to 2004. J Bone Joint Surg Br, 89, 1234-8. |
8 | Gautreau A, Poullet P, Louvard D, Arpin M (1999). Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A, 96, 7300-5. DOI |
9 | Gorlick R (2009). Current concepts on the molecular biology of osteosarcoma. Cancer Treat Res, 152, 467-78. DOI ScienceOn |
10 | Hong-Jian W, Cheng-Zhang S, Xian-Feng Q, Qiu-Shi H (2007). Expression of ezrin, E-cadherin and focal adhesion kinase in colorectal carcinoma and their clinical significances. World Chin J Digestol, 15, 5. |
11 | Hunter KW (2004). Ezrin, a key component in tumor metastasis. Trends Mol Med, 10, 201-4. DOI ScienceOn |
12 | Khanna C, Wan X, Bose S, et al (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med, 10, 182-6. DOI ScienceOn |
13 | Kim C, Shin E, Hong S, et al (2009). Clinical value of ezrin expression in primary osteosarcoma. Cancer Res Treat, 41, 138-44. DOI ScienceOn |
14 | Kim MS, Song WS, Cho WH, Lee SY, Jeon DG (2007). Ezrin expression predicts survival in stage IIB osteosarcomas. Clin Orthop Relat Res, 459, 229-36. DOI |
15 | Krishnan K, Bruce B, Hewitt S, et al (2006). Ezrin mediates growth and survival in Ewing's sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway. Clin Exp Metastasis, 23, 227-36. DOI |
16 | Kumar R, Wang RA, Bagheri-Yarmand R (2003). Emerging roles of MTA family members in human cancers. Semin Oncol, 30, 30-7. DOI |
17 | Lau J, Ioannidis JP, Schmid CH (1997). Quantitative synthesis in systematic reviews. Ann Intern Med, 127, 820-6. DOI ScienceOn |
18 | Li YG, Geng X (2010). A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma. Eur J Cancer Care (Engl), 19, 313-6. DOI ScienceOn |
19 | McClatchey AI (2003). Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer, 3, 877-83. DOI ScienceOn |
20 | Martin TA, Harrison G, Mansel RE, Jiang WG (2003). The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol, 46, 165-86. DOI ScienceOn |
21 | Moses LE, Shapiro D, Littenberg B (1993). Combining independent studies of a diagnostic test into a summary ROC curve: dataanalytic approaches and some additional considerations. Stat Med, 12, 1293-316. DOI ScienceOn |
22 | Ottaviani G, Jaffe N (2009). The etiology of osteosarcoma. Cancer Treat Res, 152, 15-32. DOI ScienceOn |
23 | Pakos EE,Ioannidis JP (2003). The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis. Cancer, 98, 581-9. DOI ScienceOn |
24 | Pakos EE, Kyzas PA, Ioannidis JP (2004). Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis. Clin Cancer Res, 10, 6208-14. DOI ScienceOn |
25 | Petitti DB (2000). Meta-analysis, decision analysis, and costeffectiveness analysis: methods for quantitative synthesis in medicine. New York, Oxford University Press. |
26 | Qu JT, Wang M, He HL, Tang Y, Ye XJ (2012). The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review. J Cancer Res Clin Oncol, 138, 819-25. DOI |
27 | Salas S, Bartoli C, Deville JL, et al (2007). Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas. Virchows Arch, 451, 999-1007. DOI |
28 | Shi RL, Li JF, Qu Y, et al (2006). Expression of Ezrin in gastric carcinoma and its significance. Zhonghua Wei Chang Wai Ke Za Zhi, 9, 433-5. |
29 | Sun CX, Robb VA,Gutmann DH (2002). Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J Cell Sci, 115, 3991-4000. DOI ScienceOn |
30 | Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5. DOI |
31 | Vaheri A, Carpen O, Heiska L, et al (1997). The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr Opin Cell Biol, 9, 659-66. DOI ScienceOn |
32 | Wang HJ, Zhu JS, Zhang Q, Sun Q, Guo H (2009). High level of ezrin expression in colorectal cancer tissues is closely related to tumor malignancy. World J Gastroenterol, 15, 2016-9. DOI ScienceOn |
33 | Wang YF, Shen JN, Xie XB, Wang J, Huang G (2011). Expression change of ezrin as a prognostic factor in primary osteosarcoma. Med Oncol, 28, S636-43. DOI ScienceOn |
34 | Xu-dong S, Feng LIN, Ping C, et al (2008). Expression of Ezrin protein and its relationship with lung metastasis and survival time of osteosarcoma patients. TUMOR, 28, 4. |
35 | Xu-Dong S, Zan S, Shui-er Z, et al (2009). Expression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma. Clin Invest Med, 32, E180-8. |
36 | You-yuan W, Wei-liang C, Zhao-hui Y, et al (2009). Effects of Ezrin gene on the proliferation and invasion activity of human salivary gland adenoid cystic carcinoma. Chin J Stomatol, 44, 5. |
37 | Yu Y, Khan J, Khanna C, et al (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med, 10, 175-81. DOI ScienceOn |